Pascal Godmer

5.3k total citations
31 papers, 802 citations indexed

About

Pascal Godmer is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Pascal Godmer has authored 31 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Hematology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Pascal Godmer's work include Vasculitis and related conditions (10 papers), Multiple Myeloma Research and Treatments (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Pascal Godmer is often cited by papers focused on Vasculitis and related conditions (10 papers), Multiple Myeloma Research and Treatments (5 papers) and Lymphoma Diagnosis and Treatment (5 papers). Pascal Godmer collaborates with scholars based in France, United States and Spain. Pascal Godmer's co-authors include Loı̈c Guillevin, Pascal Cohen, Christian Pagnoux, P Callard, Alfred Mahr, Roch Houot, Steven Le Gouill, Thierry Lamy, Xavier Puéchal and M. Hamidou and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Pascal Godmer

27 papers receiving 788 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Godmer France 13 321 189 189 187 157 31 802
Vincenzo Pitini Italy 15 162 0.5× 141 0.7× 92 0.5× 190 1.0× 183 1.2× 48 729
Jun Kishi Japan 17 462 1.4× 164 0.9× 112 0.6× 301 1.6× 84 0.5× 28 920
Francesca Bellisai Italy 21 200 0.6× 234 1.2× 313 1.7× 611 3.3× 171 1.1× 62 1.1k
I. Koetter Germany 16 146 0.5× 276 1.5× 283 1.5× 267 1.4× 149 0.9× 28 844
Taro Iwamoto Japan 13 201 0.6× 123 0.7× 323 1.7× 513 2.7× 85 0.5× 41 933
Tatiana Nevskaya Canada 14 146 0.5× 132 0.7× 162 0.9× 178 1.0× 43 0.3× 33 641
Bouchra Asli France 15 154 0.5× 618 3.3× 206 1.1× 259 1.4× 358 2.3× 30 1.1k
O. Decaux France 13 268 0.8× 164 0.9× 40 0.2× 200 1.1× 145 0.9× 45 704
Marie Maerevoet Belgium 15 131 0.4× 153 0.8× 141 0.7× 120 0.6× 92 0.6× 40 820
Fengchun Zhang China 14 218 0.7× 116 0.6× 204 1.1× 195 1.0× 30 0.2× 29 769

Countries citing papers authored by Pascal Godmer

Since Specialization
Citations

This map shows the geographic impact of Pascal Godmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Godmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Godmer more than expected).

Fields of papers citing papers by Pascal Godmer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Godmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Godmer. The network helps show where Pascal Godmer may publish in the future.

Co-authorship network of co-authors of Pascal Godmer

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Godmer. A scholar is included among the top collaborators of Pascal Godmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Godmer. Pascal Godmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hulin, Cyrille, Jérôme Lambert, Salomon Manier, et al.. (2024). Phase 3 randomized study of isatuximab (Isa) plus lenalidomide and dexamethasone (Rd) with bortezomib versus isard in patients with newly diagnosed transplant ineligible multiple myeloma (NDMM TI).. Journal of Clinical Oncology. 42(16_suppl). 7501–7501. 1 indexed citations
2.
Seguin, Amélie, C. Agard, Gauthier Blonz, et al.. (2021). Deleterious neurological impact of diagnostic delay in immune-mediated thrombotic thrombocytopenic purpura. PLoS ONE. 16(11). e0260196–e0260196. 4 indexed citations
3.
Tessoulin, Benoît, Cédric Bretonnière, J. Boileau, et al.. (2021). Catastrophic adult-onset Still’s disease as a distinct life-threatening clinical subset: case–control study with dimension reduction analysis. Arthritis Research & Therapy. 23(1). 256–256. 10 indexed citations
4.
Régny, Caroline, Lucie Obéric, Sandra Malak, et al.. (2019). PF482 CLINICAL EFFICACY OF THE RIBVD REGIMEN FOR REFRACTORY/RELAPSED (R/R) MANTLE CELL LYMPHOMA (MCL) PATIENTS: A RETROSPECTIVE STUDY OF THE LYSA GROUP. HemaSphere. 3(S1). 193–193. 1 indexed citations
5.
Desmots, Fabienne, Mikaël Roussel, Céline Pangault, et al.. (2018). Pan-HDAC Inhibitors Restore PRDM1 Response to IL21 in CREBBP-Mutated Follicular Lymphoma. Clinical Cancer Research. 25(2). 735–746. 19 indexed citations
6.
Puéchal, Xavier, Alain Le Quellec, Christian Pagnoux, et al.. (2018). Mortality in systemic necrotizing vasculitides: A retrospective analysis of the French Vasculitis Study Group registry. Autoimmunity Reviews. 17(7). 653–659. 39 indexed citations
7.
Néel, A., Benoît Tessoulin, J. Boileau, et al.. (2018). Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review. Critical Care. 22(1). 88–88. 42 indexed citations
8.
Néel, A., Mélanie Néel, Gaëlle Tilly, et al.. (2018). Dampening of CD8+ T Cell Response by B Cell Depletion Therapy in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. Arthritis & Rheumatology. 71(4). 641–650. 22 indexed citations
9.
Azzaoui, Imane, Fabrice Uhel, Delphine Rossille, et al.. (2016). T-cell defect in diffuse large B-cell lymphomas involves expansion of myeloid-derived suppressor cells. Blood. 128(8). 1081–1092. 123 indexed citations
10.
Terrier, Benjamin, Agnès Dechartres, C. Deligny, et al.. (2016). Granulomatosis with polyangiitis according to geographic origin and ethnicity: clinical-biological presentation and outcome in a French population. Lara D. Veeken. 56(3). kew423–kew423. 12 indexed citations
11.
Azzaoui, Imane, Fabrice Uhel, Delphine Rossille, et al.. (2015). T-Cell Defect in Diffuse Large B-Cell Lymphomas Involves Expansion of Myeloid Derived Suppressor Cells Expressing IL-10, PD-L1, and S100A12. Blood. 126(23). 1478–1478. 1 indexed citations
12.
Terrier, Benjamin, Paul Kaminsky, A. Le Quellec, et al.. (2014). Central nervous system involvement of granulomatosis with polyangiitis: clinical-radiological presentation distinguishes different outcomes. Lara D. Veeken. 54(3). 424–432. 64 indexed citations
13.
Marchand, Tony, Richard Lemal, Emmanuel Gyan, et al.. (2013). Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA. Annals of Oncology. 24(10). 2612–2618. 27 indexed citations
14.
Terrier, Benjamin, Christian Pagnoux, A. Karras, et al.. (2013). OP0213 Rituximab Versus Azathioprine for Maintenance in Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis (MAINRITSAN): Follow Up at 34 Months. Annals of the Rheumatic Diseases. 72. A124–A124. 8 indexed citations
15.
Guillevin, Loı̈c, Christian Pagnoux, Alexandre Karras, et al.. (2013). Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. A prospective study in 117 patients. La Presse Médicale. 42(4). 679–679. 19 indexed citations
16.
Magrangeas, Florence, Hervé Avet‐Loiseau, Wilfried Gouraud, et al.. (2012). Minor clone provides a reservoir for relapse in multiple myeloma. Leukemia. 27(2). 473–481. 83 indexed citations
17.
Cahu, Xavier, Caroline Bodet‐Milin, Éolia Brissot, et al.. (2010). 18F-fluorodeoxyglucose–positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS group. Annals of Oncology. 22(3). 705–711. 42 indexed citations
18.
Servettaz, Amélie, Pascal Godmer, Jean‐Denis Laredo, et al.. (2007). Radiological bone lesions in fibroblastic rheumatism; case report. La Presse Médicale. 36(3). 432–436. 12 indexed citations
19.
Guillevin, Loı̈c, Alfred Mahr, P Callard, et al.. (2005). Hepatitis B Virus-Associated Polyarteritis Nodosa. Medicine. 84(5). 313–322. 217 indexed citations
20.
Rouabhia, Samir, et al.. (2003). [Insulin autoimmune syndrome revealing systemic lupus erythematosus].. PubMed. 154(1). 59–60. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincenzo Pitini Breakdown of academic impact, for papers by Jun Kishi Breakdown of academic impact, for papers by Francesca Bellisai Breakdown of academic impact, for papers by I. Koetter Breakdown of academic impact, for papers by Taro Iwamoto Breakdown of academic impact, for papers by Tatiana Nevskaya Breakdown of academic impact, for papers by Bouchra Asli Breakdown of academic impact, for papers by O. Decaux Breakdown of academic impact, for papers by Marie Maerevoet Breakdown of academic impact, for papers by Fengchun Zhang
Rankless by CCL
2026